MedTrace Logo

Benign Liver Optimal Core Study (Tissue Acquisition Comparison in Benign Liver Disease)

NCT03245580 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 153

Last updated 2022-04-07

Study results available
· View outcomes & findings →

Summary

The primary purpose of this prospective, randomized, multicenter study is to evaluate and compare the amount and quality of tissue samples yielded in a liver biopsy comparing 2 different techniques of EUS guided CORE liver biopsy for benign disease. The two techniques: "modified Wet suction" and "Slow pull" technique of collecting tissue from a liver biopsy via Endoscopic Ultrasound (EUS).

Conditions

Interventions

DIAGNOSTIC_TEST

Core Liver Biopsy

Diagnostic EUS examination followed by liver biopsy to obtain core sample in benign liver disease.

Sponsors & Collaborators

  • Parkview Health

    lead OTHER

Principal Investigators

  • Neil R Sharma, MD · parkview cancer institute

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-08
Primary Completion
2020-09-15
Completion
2020-09-15
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03245580 on ClinicalTrials.gov